BioSpace News Archive

Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) and Pfizer Inc. (NYSE: PFE) today announced that the Phase 3 ARCHES trial evaluating XTANDI®

Santa Claus made a cyber stop at Cincinnati Children’s to visit patients in the hospital for the Christmas holiday

For women thinking of having a baby in the coming year, making a resolution to be as healthy as possible before conception will increase the likelihood of having a healthy pregnancy and baby, says March of Dimes, the leader in the fight for moms and babies.

KNF, technology leader in high-quality diaphragm pumps and systems for gases, vapors and liquids, has founded its new Future Lab in Hamburg.

Indivior PLC (LON: INDV) today announced the publication of the study design and participant characteristics of the RECOVER (Remission from Chronic Opioid Use-Studying Environmental and Socio-Economic Factors on Recovery) study in Contemporary Clinical Trials.

Pioneering Patent Covers Novel Cancer Treatments, Achieves New Company Milestone

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will present at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco

Kaleido Biosciences, a healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ, today announced the appointment of three new members to its Board of Directors:

Astellas Pharma Inc. and Pfizer Inc. today announced that the Phase 3 ARCHES trial evaluating XTANDI® (enzalutamide) plus androgen deprivation therapy (ADT) in men with metastatic hormone-sensitive prostate cancer (mHSPC) met its primary endpoint, significantly improving radiographic progression-free survival (rPFS) versus ADT alone.

Perrigo Company plc announced that President and CEO Murray Kessler will present at the 37th Annual J.P. Morgan Global Healthcare Conference at 5:00 PM EST on Tuesday, January 8, 2019 at the Westin St. Francis Hotel in San Francisco, California